United States · FDA National Drug Code directory
RIZATRIPTAN BENZOATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82619-112_40b947bf-a78e-6681-e063-6294a90ad145
- Product NDC
- 82619-112
- Form
- TABLET
- Composition / generic term
- rizatriptan benzoate
- Labeler
- Creekwood Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20121231
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (82619-112-01) · 82619-112-01
- 1000 TABLET in 1 BOTTLE (82619-112-02) · 82619-112-02
- 2 BLISTER PACK in 1 CARTON (82619-112-04) / 6 TABLET in 1 BLISTER PACK · 82619-112-04
- 3 BLISTER PACK in 1 CARTON (82619-112-05) / 6 TABLET in 1 BLISTER PACK · 82619-112-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →